![Fata Mrsic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fata Mrsic
Finanzdirektor/CFO bei
DIAGONAL BIO AB
Profil
Fata Mrsic currently works at Diagonal Bio AB, as Chief Financial Officer from 2024, SpectraCure AB, as Chief Financial Officer from 2026, Lumito AB, as Chief Financial Officer, and NanoEcho AB, as Chief Financial Officer from 2026.
Ms. Mrsic received her undergraduate degree from the University of Lund.
Aktive Positionen von Fata Mrsic
| Unternehmen | Position | Beginn |
|---|---|---|
| DIAGONAL BIO AB | Finanzdirektor/CFO | 14.06.2024 |
| LUMITO AB | Finanzdirektor/CFO | - |
| SPECTRACURE AB | Finanzdirektor/CFO | 01.06.2026 |
| NANOECHO AB | Finanzdirektor/CFO | 11.06.2026 |
Ausbildung von Fata Mrsic
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SpectraCure AB
 SpectraCure AB Electronic Equipment/InstrumentsElectronic Technology Develops and provides equipment for cancer treatment | Electronic Technology |
Lumito AB
 Lumito AB Medical SpecialtiesHealth Technology Develops, manufactures, and licenses imaging based on nanoparticles | Health Technology |
Nanoecho AB
 Nanoecho AB Medical SpecialtiesHealth Technology Develops medical ultrasound imaging equipment to treat rectal cancer | Health Technology |
Diagonal Bio AB
 Diagonal Bio AB Medical SpecialtiesHealth Technology Develops pathogen diagnostic systems | Health Technology |
